TerminatedNCT01717040
Pioglitazone for Depression in bipolarity
Official study title
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
This study ended early.
In ClevelandBipolarity, DepressionMedication studyAges 18+
Bipolarity studies
Bipolarity
Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
CompletedNCT01495741
Safety study of asenapine in Bipolarity
Official study title
An Observational Post-Authorization Safety Surveillance (PASS) Study of Sycrest® (Asenapine) Among Patients Aged 18 and Older Diagnosed With Bipolar Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarity, SchizophreniaObservational studyAges 18+
CompletedNCT00961961
Prevention of Relapse & Recurrence of Depression in bipolarity
Official study title
Prevention of Relapse & Recurrence of Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including ChicagoBipolarity, DepressionMedication studyAges 18+
CompletedNCT00139919
Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolarity
Official study title
A Randomized, Double-Blind, Placebo-Controlled, Sequential Panel Study of the Safety and Tolerability of Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Either Schizophrenia or Bipolar Disorder With an Optional Open-Label 26-Week Extension Study
This study has finished and is no longer accepting participants.
In OrangeBipolarity, SchizophreniaMedication studyAges 18–55
CompletedNCT00523601
Quetiapine Efficacy in Depression in bipolarity Study
Official study title
A 8-Week, Multicenter, Open-Label, Observational Study of the Efficacy of Quetiapine Fumarate (SEROQUEL) Immediate-Release Tablets in Adult Patients With Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including Kyungki-doBipolarity, DepressionObservational studyAges 18–65
CompletedNCT00227305
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent people with Schizophrenia and Bipolarity type I
Official study title
A 26-week, Multicenter, Open-label Phase 3b Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in Children and Adolescents With Bipolar I Disorder and Adolescents With Schizophrenia (Abbreviated)
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarity, SchizophreniaMedication studyAges 10–17
CompletedNCT00579280
Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolarity With Panic Disorder and/or GAD
Official study title
A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder.
This study has finished and is no longer accepting participants.
Multiple locations, including Palo AltoBipolarity, AnxietyMedication studyAges 18–65
CompletedNCT00186485
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression in bipolarity
Official study title
Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression
This study has finished and is no longer accepting participants.
In StanfordBipolarity, DepressionDevice studyAges 18+
CompletedNCT01586793
Repetitive Transcranial Magnetic Stimulation for Treating Resistant Depression in bipolarity
Official study title
A Randomized Trial Comparing the Effectiveness and Tolerability of High and Low Frequency Repetitive Transcranial Magnetic Stimulation for Treating Resistant Bipolar Depression: An Exploratory Study
This study has finished and is no longer accepting participants.
In VerdunBipolarity, DepressionDevice studyAges 18–70
CompletedNCT00183352
Reproductive Function and Mood in Women With Bipolarity
Official study title
Reproductive Endocrine Function and Mood Over the Menstrual Cycle of Women Treated for Bipolar Disorder
This study has finished and is no longer accepting participants.
In StanfordBipolarityObservational studyAges 18–40
CompletedNCT00544544
Riluzole in the Treatment of Depression in bipolarity
What is this study about?
Researchers studied Riluzole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
In BelmontBipolarity, DepressionMedication studyAges 18–65
TerminatedNCT00054704
Riluzole to Treat Depression in Bipolarity
What is this study about?
Researchers are comparing Riluzole and placebo to find out how the approaches affect depression symptoms in people with bipolarity during a depressive episode.
This study ended early.
In BethesdaBipolarity, DepressionMedication studyAges 18–70
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.